Emphysema

Emphysema is a lung condition where the tiny air sacs (alveoli) in your lungs are damaged. This makes it hard to breathe, especially when you exercise. It's often caused by smoking.

Condition

What people with Emphysema report

Every report comes from a Lived member, sent anonymously.

Have you tried Spiriva (Tiotropium) for Emphysema?

NameHow it went

About Emphysema

What It Is

Emphysema is a long-term lung disease in which the tiny air sacs at the ends of the airways are damaged. Healthy air sacs (alveoli) are stretchy: they fill like small balloons when you breathe in and deflate as you breathe out. In emphysema, the walls between many of them break down, leaving fewer, larger and floppier spaces. Air gets trapped in the lungs, and less oxygen passes into the blood. The main symptom is shortness of breath that builds slowly, first during exertion such as climbing stairs and later with everyday activity. A lasting cough, wheezing, chest tightness and tiredness are also common. Early on there may be few or no symptoms. Emphysema is one of the main forms of chronic obstructive pulmonary disease (COPD), a group of lung diseases that limit airflow and tend to worsen over time. Most people with COPD have both emphysema and chronic bronchitis (long-term inflammation of the airways), in proportions that differ from person to person.

Causes & Risk Factors

Most emphysema is caused by breathing in substances that damage the lungs over many years. In the United States, cigarette smoking is the leading cause, and up to three in four people with emphysema smoke or used to smoke. Pipe and cigar smoke, secondhand smoke, air pollution, smoke from cooking or heating fuels burned without good ventilation, and chemical fumes or dusts at work can also contribute. Symptoms usually begin at age 40 or older, after years of exposure. Family history plays a part: people who smoke are more likely to develop COPD if relatives have it. Conditions that affect lung growth before birth or in childhood, such as smoking during pregnancy or childhood asthma, and infections such as HIV and tuberculosis can also raise risk. A less common, inherited cause is alpha-1 antitrypsin deficiency. Alpha-1 antitrypsin is a protein made by the liver that helps protect the lungs from inflammation. People who inherit too little of it can develop emphysema at a younger age, especially if they smoke or breathe in dust or fumes.

How It's Diagnosed

Diagnosis starts with your symptoms, smoking and work history, and any family history of lung disease, along with listening to your chest. The key test is spirometry. You take a deep breath and blow out as hard and fast as you can into a tube attached to a measuring device. It records how much air you blow out in the first second (FEV1, forced expiratory volume in one second) and the total you can blow out (FVC, forced vital capacity). The test is usually repeated after you inhale a medicine that opens the airways. Damaged lungs empty slowly, so less of the total comes out in that first second. Under the widely used criteria of the Global Initiative for Chronic Obstructive Lung Disease (GOLD), airflow is considered obstructed when, after the airway-opening medicine, the FEV1 is less than 70 percent of the FVC (a ratio below 0.7). For example, someone who blows out 4 liters in total but only 2.4 liters in the first second has a ratio of 0.6. Results close to the cutoff may be repeated, and the numbers also help gauge how severe the disease is. A chest CT scan can show the damaged air sacs and how much of the lung is affected, and can look for other problems. A chest X-ray cannot diagnose COPD but can reveal other conditions. In more advanced disease, a blood test may measure oxygen and carbon dioxide levels. Once COPD is diagnosed, guidelines suggest testing for alpha-1 antitrypsin deficiency, because a positive result changes treatment options and matters for blood relatives.

Treatment Options

There is no cure, and lung tissue destroyed by emphysema does not grow back. Treatment aims to ease breathlessness, prevent flare-ups, keep you active and slow further damage. For people who smoke, quitting is the most important step: it slows the disease and can help people live longer. A care team can suggest support programs and products that make quitting easier. Federal health guidance advises people with COPD not to switch to e-cigarettes or vaping as a way to quit. Most medicines are inhaled. Bronchodilators relax the muscles around the airways so air moves more easily. Short-acting ones last about 4 to 6 hours and may be enough when symptoms come and go. Long-acting ones last 12 hours or more and are taken every day when symptoms are more persistent. People who have frequent flare-ups may add an inhaled steroid to reduce airway inflammation. Newer add-on options include ensifentrine (Ohtuvayre), a nonsteroid medicine inhaled through a nebulizer twice a day that both widens the airways and reduces inflammation, and dupilumab (Dupixent), an injected medicine for adults whose COPD remains poorly controlled and who have a type of inflammation marked by high levels of eosinophils, a kind of white blood cell. Inhalers only work well with the right technique, which is worth checking with your care team. Pulmonary rehabilitation is a supervised program of exercise training, education and breathing techniques that helps many people breathe more comfortably and do more. People whose blood oxygen is low may be prescribed oxygen through tubing at the nose or a mask, either all the time or only at certain times. Oxygen is a fire risk, so no one should smoke or use open flames or other flammable materials near it. Staying up to date on flu, pneumonia and COVID-19 vaccines, and the respiratory syncytial virus (RSV) vaccine at age 60 or older, lowers the chance of infections that set off flare-ups. For some people with severe emphysema whose symptoms persist despite medicines, procedures can help. Lung volume reduction surgery removes the most damaged tissue so the healthier lung works better, and one-way valves placed in an airway (endobronchial valves) let trapped air escape from a damaged section. Very large air spaces (bullae) can be removed, and a lung transplant may be considered for very severe disease, though it requires lifelong medicines to prevent rejection. People with severe alpha-1 antitrypsin deficiency may be offered regular infusions of the missing protein (augmentation therapy) by a specialist. It is meant to slow lung damage, but trials have not shown that it reduces flare-ups or helps people live longer.

What to Expect

Emphysema usually progresses slowly over years, and the pace varies a great deal between people. Quitting smoking is the single biggest factor in slowing it. With mild disease, many people notice little beyond getting winded more easily and can adapt by pacing themselves. With more severe disease, everyday tasks such as dressing, cooking or climbing stairs take planning, and appetite, weight and muscle strength may fall. Anxiety and depression are common in long-term breathing conditions and are worth raising, since they can be treated. Most people have flare-ups (exacerbations) from time to time: periods when symptoms worsen over hours or days, often set off by a cold, flu, lung infection, smoke or poor air quality. They are usually treated with antibiotics when infection is likely, steroids and stronger airway-opening medicines, and severe flare-ups may need hospital care. Agreeing on a written flare-up plan with your care team means you know which medicines to start and when. Day to day, staying as active as you safely can keeps the breathing muscles stronger. Smaller, more frequent meals help when breathlessness makes eating tiring. On days with poor air quality or wildfire smoke, staying indoors and using an air filter can reduce flare-ups. Regular visits let the care team recheck lung function, review inhaler technique, adjust medicines and watch for related conditions such as heart disease, which is common in people with COPD.

When to Seek Help

Make an appointment if you notice shortness of breath that is slowly getting worse, a cough that lingers or regularly brings up mucus, or wheezing, especially if you smoke, used to smoke, or have worked around dust or fumes. Diagnosis and treatment before symptoms become severe can make a real difference. If you already have emphysema, call your care team right away if your breathing suddenly becomes harder than usual, or if you develop a fever or cough up more yellow or green phlegm, which can signal an infection. Prompt treatment can stop a flare-up from becoming severe. Call 911 if you are struggling to catch your breath or to speak, your lips or fingernails look blue or gray, you seem confused or less alert than usual, your heart is racing, or your breathing keeps getting worse despite the treatment your care team recommended.

Questions to Ask Your Doctor

  1. 1.How much lung function have I lost, and how will we track whether it is changing?
  2. 2.Should I be tested for alpha-1 antitrypsin deficiency, and what would a positive result mean for my family?
  3. 3.Am I using my inhalers correctly, and is this the best type of device for me?
  4. 4.What should my flare-up plan include, and at what point should I start it?
  5. 5.Would pulmonary rehabilitation, oxygen or a lung procedure help me at this stage?

Last reviewed • Oct 2026

Educational content, not medical advice.